PG
FY2026 Q3 · Calendar Q2 2026
The Procter & Gamble Company
P&G delivered a Q3 FY26 beat with EPS of $1.59 versus $1.56 estimated and revenue of $21.24B versus $20.53B estimated, as organic sales grew over 3% across all ten categories and seven regions. However, roughly $1 billion in after-tax cost headwinds from commodity, energy, and logistics pressures linked to Middle East geopolitical disruption are pressing margins. Management maintained FY26 guidance but now expects full-year EPS toward the lower end of the $6.83-$7.09 range. The stock saw a modest +0.92% abnormal return on the report day but drifted approximately 2.5% lower over the subsequent period, suggesting the market tempered its initial reception as the cost-pressure caveat sank in. At $148.66, the stock trades about 7% below the analyst consensus target of $159.75.
EPS surprise+1.9%
Market move+1.7%
